What is the recommended management for a patient with uncontrolled hypertension, including confirming accurate blood pressure measurements, assessing medication adherence and lifestyle factors, and appropriate pharmacologic adjustments?

Management of Uncontrolled Hypertension

For adults with uncontrolled hypertension, immediately verify accurate BP measurement with out-of-office monitoring, assess medication adherence, and implement team-based care with systematic medication intensification to achieve BP <130/80 mmHg within 3 months. 1, 2, 3

Step 1: Confirm True Uncontrolled Hypertension

Before escalating therapy, you must rule out pseudoresistance:

• Verify measurement accuracy: Use a validated automated upper arm cuff with appropriate cuff size. Office BP ≥140/90 mmHg must be confirmed with home BP ≥135/85 mmHg or 24-hour ambulatory BP ≥130/80 mmHg 1
• Check medication adherence: Non-adherence is the most common cause of apparent treatment failure 4, 5
• Identify interfering substances: NSAIDs, decongestants, excessive alcohol (>100g/week), high sodium intake, and licorice can all elevate BP 3, 6
• Rule out white coat effect: This requires out-of-office BP confirmation 1, 4

Step 2: Optimize Current Regimen Before Adding Medications

Ensure you're using the right drugs at the right doses:

For Non-Black Patients:

1. Start with low-dose ACE inhibitor or ARB
2. Add dihydropyridine calcium channel blocker (CCB)
3. Uptitrate both to maximum tolerated doses
4. Add thiazide-like diuretic (chlorthalidone or indapamide preferred over hydrochlorothiazide)
5. Ensure all three are at optimal doses before declaring resistance 1

For Black Patients:

1. Start with low-dose ARB + dihydropyridine CCB or CCB + thiazide-like diuretic
2. Uptitrate to maximum doses
3. Add the missing component (diuretic or ARB/ACE inhibitor)
4. Maximize all doses before adding fourth agent 1

Critical pitfall: Many patients labeled as "resistant" are simply on suboptimal regimens—wrong drug classes, inadequate doses, or missing a diuretic 4, 6, 5.

Step 3: Implement Team-Based Care

Team-based care with protocol-driven medication titration reduces SBP by 7.1 mmHg and dramatically improves control rates (from 61% to 90% in the MAP study) 2, 7. Your team should include:

• Nurses or pharmacists empowered to titrate medications per protocol
• Monthly follow-up until BP is controlled 2
• Home BP monitoring with clinical support 2, 7
• Addressing social determinants of health that impede adherence 2

The 2025 AHA/ACC guidelines give this a Class I, Level A recommendation—the strongest evidence grade available 2.

Step 4: Add Fourth-Line Agent for True Resistant Hypertension

If BP remains ≥140/90 mmHg despite maximum doses of ACE inhibitor/ARB + CCB + thiazide-like diuretic:

Spironolactone is the preferred fourth-line agent (12.5-50 mg daily). The PATHWAY-2 trial demonstrated superior BP reduction with spironolactone compared to other fourth-line options 6, 5.

Alternatives if spironolactone is contraindicated or not tolerated:

• Amiloride (potassium-sparing, useful if hyperkalemia risk)
• Doxazosin (alpha-blocker)
• Eplerenone (selective mineralocorticoid receptor antagonist)
• Clonidine (central alpha-agonist)
• Beta-blocker (if compelling indication like CAD or heart failure) 1, 6

Step 5: Lifestyle Interventions (Non-Negotiable)

These must be addressed concurrently, not sequentially:

• Sodium restriction: <2g/day (reduces SBP by 5-6 mmHg) 3
• Weight loss: Target BMI 20-25 kg/m² and waist <94 cm (men) or <80 cm (women) 3
• Alcohol reduction: <100g/week maximum, ideally none 3
• Exercise: 150 minutes/week moderate aerobic activity plus resistance training 2-3 times/week 3
• DASH or Mediterranean diet 3
• Eliminate sugar-sweetened beverages 3

Step 6: Screen for Secondary Hypertension

Consider secondary causes if:

• Age <30 years with hypertension
• Sudden onset or worsening despite good prior control
• Resistant to 4+ medications
• Hypokalemia (suggests primary aldosteronism)
• Abdominal bruit (renovascular disease)
• Variable BP with headaches, palpitations, sweating (pheochromocytoma) 1, 4, 5

Target BP and Timeline

Target systolic BP 120-129 mmHg for most adults (ESC 2024 and AHA/ACC 2025 guidelines) 3, 8. The 2020 ISH guidelines suggest <130/80 mmHg as optimal, with a minimum acceptable target of <140/90 mmHg 1.

Achieve control within 3 months with monthly medication adjustments 1, 2. If BP remains uncontrolled after optimizing 4-drug therapy, refer to hypertension specialist 1.

Common Pitfalls to Avoid

1. Therapeutic inertia: Failing to intensify therapy at each visit when BP is above goal. The MAP protocol reduced therapeutic inertia from 52% to 49.5% and achieved 12.7 mmHg SBP reduction per intensification 7
2. Using hydrochlorothiazide instead of chlorthalidone/indapamide: Thiazide-like diuretics are more effective 6
3. Not maximizing doses before adding drugs: Each medication should be at optimal dose
4. Ignoring adherence: Use pill counts, pharmacy refill data, or directly observed therapy if needed 4, 5
5. Inadequate BP measurement technique: This creates false readings that lead to inappropriate treatment decisions 7

Role of Technology

Telehealth and electronic health records improve BP control (Class I, Level B-R recommendation) 2. Use patient registries to identify uncontrolled patients, implement automated BP measurement protocols, and leverage asynchronous communication for medication adjustments between visits 2.